JORDEN DAVID EMERSON
CEO/CFO
JORDEN DAVID EMERSON has filed 6 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Aug 31, 2026.
On the most recent filing, JORDEN DAVID EMERSON is listed as CEO/CFO at Nuo Therapeutics, Inc. Inside the rolling window, JORDEN DAVID EMERSON reported 2 open-market purchases totaling $10K in AURX and 1 open-market sale totaling $300K in AURX. The largest disclosed transaction in the window is a sale of 200,000 AURX shares on Nov 28, 2025, worth $300K.
Companies traded
Other insiders at AURX
Insider Buying
$10K
reported purchases (SEC code P)
Insider Selling
$300K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has JORDEN DAVID EMERSON made?
JORDEN DAVID EMERSON has filed 6 SEC Form 4 filings (10 transaction rows) across 1 company since 2025.
Which companies does JORDEN DAVID EMERSON trade?
JORDEN DAVID EMERSON has filed SEC Form 4 disclosures for 1 company, including AURX.
When was JORDEN DAVID EMERSON's most recent SEC Form 4 filing?
JORDEN DAVID EMERSON's most recent SEC Form 4 filing on Tracefour is dated Aug 31, 2026.
What is JORDEN DAVID EMERSON's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, JORDEN DAVID EMERSON is listed as CEO/CFO.
What is JORDEN DAVID EMERSON's total buy and sell value in the current window?
Inside the rolling retention window, JORDEN DAVID EMERSON bought $10K and sold $300K based on SEC Form 4 filings.
What was JORDEN DAVID EMERSON's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 200,000 AURX shares on 2025-11-28, worth $300K, per SEC Form 4 filings.